Ligand validation:8B20

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8B20_EPE_B_304	84%	49%	0.106	0.967	0.86	1.09	1	2	0	0	100%	1
6TWT_EPE_B_301	86%	31%	0.092	0.962	1.95	0.83	1	-	0	0	100%	0.8
8A76_EPE_B_305	63%	45%	0.152	0.947	0.79	1.32	1	2	0	0	100%	1
6Q2Y_EPE_B_306	50%	12%	0.158	0.909	1.95	2.11	2	6	0	0	100%	0.8
8B1Z_EPE_A_305	49%	53%	0.196	0.943	0.77	1.04	1	-	0	0	100%	0.5
7UP3_EPE_B_306	42%	67%	0.2	0.922	0.93	0.35	1	-	1	0	100%	1
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
3TGT_EPE_A_1	99%	42%	0.051	0.979	0.93	1.33	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.